Time without symptoms and toxicity (TWIST) analysis of adjuvant radiation therapy for endometrial cancer

Barbara A. Jereczek-Fossa, Andrzej Badzio, Jacek Jassem

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Background and purpose Postoperative radiotherapy in endometrial cancer reduces the risk of local relapse but is also associated with substantial acute and late reactions. The aim of our study was to evaluate time without tumor symptoms and toxicity (TWIST) in a consecutive series of 317 endometrial cancer patients administered postoperative irradiation. Patients and methods Both low-dose rate brachytherapy (BRT) and external beam irradiation (EBRT) were applied in 247 patients (78%), only BRT - in 49 (15%) and only EBRT - in 21 patients (7%). Median follow-up was 7.3 years (range, 4-21 years). TWIST analysis based on actuarial freedom from recurrent disease and from late radiotherapy effects was performed with the use of Kaplan-Meier method. The impact of patient- and treatment-related factors on TWIST was assessed with uni- and multivariate tests. Results Five-year overall survival was 78%, and five-year disease free survival - 75%. Recurrence occurred in 70 patients (22%), of whom in 11 (3.5%) - exclusively in the pelvis. Acute and late reactions of any grade occurred in 268 (85%) and 158 patients (51%), respectively. Late bowel effects of any grade were observed in 41% of patients. Severe late effects occurred in 35 patients (11%). Actuarial probability of two- and five-year survival free of disease and severe (grades 3 or 4) late effects (TWIST) was 84% and 71%, respectively (median TWIST, 16.2 years). When all-grade late effects were considered, two- and five-year TWIST probability was 50 and 30%, respectively, and median TWIST was only 2.0 years. When both acute and late reactions were taken into account, median TWIST was 22 months. In unifactorial test, higher age (P=0.013), FIGO stage (P

Original languageEnglish
Pages (from-to)175-181
Number of pages7
JournalRadiotherapy and Oncology
Volume72
Issue number2
DOIs
Publication statusPublished - Aug 2004

Fingerprint

Endometrial Neoplasms
Radiotherapy
Brachytherapy
Disease-Free Survival
Recurrence
Pelvis
Survival

Keywords

  • Acute and late reactions
  • Adjuvant radiotherapy
  • Endometrial cancer
  • Quality of life
  • Recurrent disease
  • Time without tumor symptoms and toxicity

ASJC Scopus subject areas

  • Oncology
  • Radiology Nuclear Medicine and imaging
  • Urology

Cite this

Time without symptoms and toxicity (TWIST) analysis of adjuvant radiation therapy for endometrial cancer. / Jereczek-Fossa, Barbara A.; Badzio, Andrzej; Jassem, Jacek.

In: Radiotherapy and Oncology, Vol. 72, No. 2, 08.2004, p. 175-181.

Research output: Contribution to journalArticle

@article{450808f69a584023a2bf8d3e01b00b7f,
title = "Time without symptoms and toxicity (TWIST) analysis of adjuvant radiation therapy for endometrial cancer",
abstract = "Background and purpose Postoperative radiotherapy in endometrial cancer reduces the risk of local relapse but is also associated with substantial acute and late reactions. The aim of our study was to evaluate time without tumor symptoms and toxicity (TWIST) in a consecutive series of 317 endometrial cancer patients administered postoperative irradiation. Patients and methods Both low-dose rate brachytherapy (BRT) and external beam irradiation (EBRT) were applied in 247 patients (78{\%}), only BRT - in 49 (15{\%}) and only EBRT - in 21 patients (7{\%}). Median follow-up was 7.3 years (range, 4-21 years). TWIST analysis based on actuarial freedom from recurrent disease and from late radiotherapy effects was performed with the use of Kaplan-Meier method. The impact of patient- and treatment-related factors on TWIST was assessed with uni- and multivariate tests. Results Five-year overall survival was 78{\%}, and five-year disease free survival - 75{\%}. Recurrence occurred in 70 patients (22{\%}), of whom in 11 (3.5{\%}) - exclusively in the pelvis. Acute and late reactions of any grade occurred in 268 (85{\%}) and 158 patients (51{\%}), respectively. Late bowel effects of any grade were observed in 41{\%} of patients. Severe late effects occurred in 35 patients (11{\%}). Actuarial probability of two- and five-year survival free of disease and severe (grades 3 or 4) late effects (TWIST) was 84{\%} and 71{\%}, respectively (median TWIST, 16.2 years). When all-grade late effects were considered, two- and five-year TWIST probability was 50 and 30{\%}, respectively, and median TWIST was only 2.0 years. When both acute and late reactions were taken into account, median TWIST was 22 months. In unifactorial test, higher age (P=0.013), FIGO stage (P",
keywords = "Acute and late reactions, Adjuvant radiotherapy, Endometrial cancer, Quality of life, Recurrent disease, Time without tumor symptoms and toxicity",
author = "Jereczek-Fossa, {Barbara A.} and Andrzej Badzio and Jacek Jassem",
year = "2004",
month = "8",
doi = "10.1016/j.radonc.2004.04.006",
language = "English",
volume = "72",
pages = "175--181",
journal = "Radiotherapy and Oncology",
issn = "0167-8140",
publisher = "Elsevier Ireland Ltd",
number = "2",

}

TY - JOUR

T1 - Time without symptoms and toxicity (TWIST) analysis of adjuvant radiation therapy for endometrial cancer

AU - Jereczek-Fossa, Barbara A.

AU - Badzio, Andrzej

AU - Jassem, Jacek

PY - 2004/8

Y1 - 2004/8

N2 - Background and purpose Postoperative radiotherapy in endometrial cancer reduces the risk of local relapse but is also associated with substantial acute and late reactions. The aim of our study was to evaluate time without tumor symptoms and toxicity (TWIST) in a consecutive series of 317 endometrial cancer patients administered postoperative irradiation. Patients and methods Both low-dose rate brachytherapy (BRT) and external beam irradiation (EBRT) were applied in 247 patients (78%), only BRT - in 49 (15%) and only EBRT - in 21 patients (7%). Median follow-up was 7.3 years (range, 4-21 years). TWIST analysis based on actuarial freedom from recurrent disease and from late radiotherapy effects was performed with the use of Kaplan-Meier method. The impact of patient- and treatment-related factors on TWIST was assessed with uni- and multivariate tests. Results Five-year overall survival was 78%, and five-year disease free survival - 75%. Recurrence occurred in 70 patients (22%), of whom in 11 (3.5%) - exclusively in the pelvis. Acute and late reactions of any grade occurred in 268 (85%) and 158 patients (51%), respectively. Late bowel effects of any grade were observed in 41% of patients. Severe late effects occurred in 35 patients (11%). Actuarial probability of two- and five-year survival free of disease and severe (grades 3 or 4) late effects (TWIST) was 84% and 71%, respectively (median TWIST, 16.2 years). When all-grade late effects were considered, two- and five-year TWIST probability was 50 and 30%, respectively, and median TWIST was only 2.0 years. When both acute and late reactions were taken into account, median TWIST was 22 months. In unifactorial test, higher age (P=0.013), FIGO stage (P

AB - Background and purpose Postoperative radiotherapy in endometrial cancer reduces the risk of local relapse but is also associated with substantial acute and late reactions. The aim of our study was to evaluate time without tumor symptoms and toxicity (TWIST) in a consecutive series of 317 endometrial cancer patients administered postoperative irradiation. Patients and methods Both low-dose rate brachytherapy (BRT) and external beam irradiation (EBRT) were applied in 247 patients (78%), only BRT - in 49 (15%) and only EBRT - in 21 patients (7%). Median follow-up was 7.3 years (range, 4-21 years). TWIST analysis based on actuarial freedom from recurrent disease and from late radiotherapy effects was performed with the use of Kaplan-Meier method. The impact of patient- and treatment-related factors on TWIST was assessed with uni- and multivariate tests. Results Five-year overall survival was 78%, and five-year disease free survival - 75%. Recurrence occurred in 70 patients (22%), of whom in 11 (3.5%) - exclusively in the pelvis. Acute and late reactions of any grade occurred in 268 (85%) and 158 patients (51%), respectively. Late bowel effects of any grade were observed in 41% of patients. Severe late effects occurred in 35 patients (11%). Actuarial probability of two- and five-year survival free of disease and severe (grades 3 or 4) late effects (TWIST) was 84% and 71%, respectively (median TWIST, 16.2 years). When all-grade late effects were considered, two- and five-year TWIST probability was 50 and 30%, respectively, and median TWIST was only 2.0 years. When both acute and late reactions were taken into account, median TWIST was 22 months. In unifactorial test, higher age (P=0.013), FIGO stage (P

KW - Acute and late reactions

KW - Adjuvant radiotherapy

KW - Endometrial cancer

KW - Quality of life

KW - Recurrent disease

KW - Time without tumor symptoms and toxicity

UR - http://www.scopus.com/inward/record.url?scp=3543088548&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=3543088548&partnerID=8YFLogxK

U2 - 10.1016/j.radonc.2004.04.006

DO - 10.1016/j.radonc.2004.04.006

M3 - Article

C2 - 15297136

AN - SCOPUS:3543088548

VL - 72

SP - 175

EP - 181

JO - Radiotherapy and Oncology

JF - Radiotherapy and Oncology

SN - 0167-8140

IS - 2

ER -